Skip to main content

Table 3 Comparison between the two studied periods according to hematologic parameters in each group

From: Intermittent fasting during adjuvant chemotherapy may promote differential stress resistance in breast cancer patients

Hematologic parameters Intermittent fasting (n = 24) Non-fasting (n = 24)
Baseline After cycle 4 P Baseline After cycle 4 P
RBC (× 106/µl) 4.89 ± 0.45 4.61 ± 0.53 (0.004**) 4.99 ± 0.45 4.61 ± 0.72 (0.016*)
HG (g/dl) 12.35 ± 1.45 11.65 ± 1.27 (0.001**) 12.36 ± 1.19 11.89 ± 1.30 (0.002**)
PLT (× 103/µl) 317.5 ± 73.23 383.6 ± 79.85 (< 0.001***) 309.71 ± 112.41 376.04 ± 119.97 (0.009**)
WBC (× 103/µl) 8.33 ± 2.92 5.87 ± 1.87 (< 0.001***) 6.54 ± 1.44 5.98 ± 2.33 (0.152)
NEUT (× 103/mm3) 5.08 ± 2.82 3.45 ± 1.46 (< 0.001***) 3.54 ± 1.07 3.76 ± 1.65 (0.493)
  1. RBC red blood cells, HG hemoglobin, PLT platelets, WBC white blood cells, NEUT, neutrophils
  2. Data presented as mean ± SD. P P-value for comparing between baseline and after cycle 4 in each group
  3. *P < 0.05
  4. **P < 0.01
  5. ***P < 0.001